{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:27:39Z","timestamp":1789939659651,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.tiv.2014.10.019","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T05:11:56Z","timestamp":1414645916000},"page":"251-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir"],"prefix":"10.1016","volume":"29","author":[{"given":"Xun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruduan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Piotrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.tiv.2014.10.019_b0005","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ki.1997.457","article-title":"Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Technical note","volume":"52","author":"Baer","year":"1997","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.tiv.2014.10.019_b0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tox.2009.01.006","article-title":"Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells","volume":"258","author":"Cai","year":"2009","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.tiv.2014.10.019_b0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/clpt.2013.78","article-title":"Intracellular drug concentrations and transporters: measurement, modeling, and implications for the liver","volume":"94","author":"Chu","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.tiv.2014.10.019_b0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":"The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.tiv.2014.10.019_b0025","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca\u2019s drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"11","key":"10.1016\/j.tiv.2014.10.019_b0030","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/AAC.39.11.2401","article-title":"Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients","volume":"39","author":"Cundy","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.tiv.2014.10.019_b0035","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1128\/AAC.39.6.1247","article-title":"Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients","volume":"39","author":"Cundy","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.019_b0040","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/AAC.49.2.680-684.2005","article-title":"Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers","volume":"49","author":"Droste","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.019_b0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00441-007-0521-4","article-title":"Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures","volume":"331","author":"Elberg","year":"2008","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.019_b0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol. Toxicol."},{"issue":"17","key":"10.1016\/j.tiv.2014.10.019_b0055","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1016\/j.bmcl.2010.06.129","article-title":"Using an in vitro cytotoxicity assay to aid in compound selection for in vivo safety studies","volume":"20","author":"Greene","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.tiv.2014.10.019_b0060","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab. Dispos.: Biol. Fate Chem."},{"issue":"3","key":"10.1016\/j.tiv.2014.10.019_b0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","article-title":"Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1","volume":"11","author":"Ho","year":"2000","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"issue":"3","key":"10.1016\/j.tiv.2014.10.019_b0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"International Transporter Consortium","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"5","key":"10.1016\/j.tiv.2014.10.019_b0075","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"issue":"6","key":"10.1016\/j.tiv.2014.10.019_b0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-012-1163-2","article-title":"The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule","volume":"464","author":"Jenkinson","year":"2012","journal-title":"Pflugers Arch."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.019_b0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/toxsci\/kft247","article-title":"Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers","volume":"137","author":"Keirstead","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.019_b0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/44.2.97","article-title":"Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys","volume":"44","author":"Lacy","year":"1998","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.tiv.2014.10.019_b0095","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.tiv.2010.07.014","article-title":"Translation of novel anti-cancer cytotoxicity biomarkers detected with high content analysis from an in vitro predictive model to an in vivo cell model","volume":"24","author":"Lieggi","year":"2010","journal-title":"Toxicol. In Vitro: Int. J. Published Assoc. BIBRA"},{"issue":"1","key":"10.1016\/j.tiv.2014.10.019_b0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00204-011-0733-y","article-title":"Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism","volume":"86","author":"Lin","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.tiv.2014.10.019_b0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/138620710790596736","article-title":"Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance","volume":"13","author":"McKim","year":"2010","journal-title":"Comb. Chem. High Throughput Screening"},{"issue":"9\u201310","key":"10.1016\/j.tiv.2014.10.019_b0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.drudis.2011.12.020","article-title":"Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival","volume":"17","author":"Morgan","year":"2012","journal-title":"Drug Discovery Today"},{"issue":"4","key":"10.1016\/j.tiv.2014.10.019_b0115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ki.2012.442","article-title":"Human embryonic stem cells differentiate into functional renal proximal tubular-like cells","volume":"83","author":"Narayanan","year":"2013","journal-title":"Kidney Int."},{"issue":"Suppl 2","key":"10.1016\/j.tiv.2014.10.019_b0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1289\/ehp.98106559","article-title":"Nephrotoxicity testing in vitro\u2013what we know and what we need to know","volume":"106","author":"Pfaller","year":"1998","journal-title":"Environ. Health Perspect."},{"issue":"12","key":"10.1016\/j.tiv.2014.10.019_b0125","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nrd4164","article-title":"Does size matter in R&D productivity? If not, what does?","volume":"12","author":"Ringel","year":"2013","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"12","key":"10.1016\/j.tiv.2014.10.019_b0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nrd3287","article-title":"The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery","volume":"9","author":"Smith","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"4","key":"10.1016\/j.tiv.2014.10.019_b0135","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","article-title":"Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2)","volume":"24","author":"Uwai","year":"2007","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.tiv.2014.10.019_b0140","doi-asserted-by":"crossref","first-page":"e80113","DOI":"10.1371\/journal.pone.0080113","article-title":"Exposure to nerve growth factor worsens nephrotoxic effect induced by cyclosporine A in HK-2 cells","volume":"8","author":"Vizza","year":"2013","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.tiv.2014.10.019_b0145","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1016\/j.bmcl.2009.03.109","article-title":"Defining optimum lipophilicity and molecular weight ranges for drug candidates-Molecular weight dependent lower logD limits based on permeability","volume":"19","author":"Waring","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.tiv.2014.10.019_b0150","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.bcp.2011.01.004","article-title":"Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1\/SLC22A6)","volume":"81","author":"Wong","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2014.10.019_b0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1479-5876-11-24","article-title":"Berberine protects human renal proximal tubular cells from hypoxia\/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways","volume":"11","author":"Yu","year":"2013","journal-title":"J. Translational Med."},{"issue":"1","key":"10.1016\/j.tiv.2014.10.019_b0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/toxsci\/kft085","article-title":"Detection of statin cytotoxicity is increased in cells expressing the OATP1B1 transporter","volume":"134","author":"Zhang","year":"2013","journal-title":"Toxicol. Sci."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314002100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233314002100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T22:26:42Z","timestamp":1650493602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233314002100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0887233314002100"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2014.10.019","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2014.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}